Literature DB >> 23465677

Esophagectomy after chemoradiation: who and when to operate.

Jae Y Kim1, Wayne L Hofstetter.   

Abstract

Neoadjuvant chemoradiation is the standard of care for locally advanced esophageal cancer. After completion of chemoradiotherapy, deciding which patients benefit from surgery remains a challenge. For patients who decide on surgery, the optimal timing is unknown. The complexity of these questions requires an individualized approach, taking into account the expertise of the surgeon, the condition of the patient, and the biology of the tumor. Published by Elsevier Inc.

Entities:  

Mesh:

Year:  2012        PMID: 23465677     DOI: 10.1053/j.semtcvs.2012.10.005

Source DB:  PubMed          Journal:  Semin Thorac Cardiovasc Surg        ISSN: 1043-0679


  4 in total

1.  [Timing of esophagectomy in multimodal therapy of esophageal cancer: Impact of time interval between neoadjuvant therapy and surgery on outcome and response].

Authors:  A-K Müller; C Lenschow; D Palmes; N Senninger; R Hummel; K Lindner
Journal:  Chirurg       Date:  2015-09       Impact factor: 0.955

Review 2.  How does genome sequencing impact surgery?

Authors:  Marlies S Reimers; Charla C Engels; Peter J K Kuppen; Cornelis J H van de Velde; Gerrit J Liefers
Journal:  Nat Rev Clin Oncol       Date:  2014-06-24       Impact factor: 66.675

Review 3.  Machine learning applications in upper gastrointestinal cancer surgery: a systematic review.

Authors:  Mustafa Bektaş; George L Burchell; H Jaap Bonjer; Donald L van der Peet
Journal:  Surg Endosc       Date:  2022-08-11       Impact factor: 3.453

4.  Surgery is an essential component of multimodality therapy for patients with locally advanced esophageal adenocarcinoma.

Authors:  Caitlin C Murphy; Arlene M Correa; Jaffer A Ajani; Ritsuko U Komaki; James W Welsh; Stephen G Swisher; Wayne L Hofstetter
Journal:  J Gastrointest Surg       Date:  2013-05-29       Impact factor: 3.452

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.